Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remissionl

被引:8
作者
Fond, G. [1 ,2 ]
Faugere, M. [1 ,2 ]
Richieri, R. [2 ]
Cermolacce, M. [1 ]
Korchia, T. [1 ]
Micoulaud-Franchi, J. A. [3 ]
de Verville, P. L. Sunhary [1 ,2 ]
Boyer, L. [1 ,2 ]
Lancon, C. [1 ,2 ]
机构
[1] Hop Univ Marseille, Dept Psychiat, F-13005 Marseille, France
[2] CEReSS Hlth Serv Res & Qual Life Ctr, EA 3279, 27 Blvd Jean Moulin, F-13005 Marseille, France
[3] Univ Bordeaux, CHU Pellegrin, USR CNRS SANPSY 3413, Bordeaux, France
关键词
Psychiatry; Schizophrenia; Depression; Inflammation; Remission; C-REACTIVE PROTEIN; COGNITIVE IMPAIRMENT; DISORDERS; SCALE;
D O I
10.1016/j.jad.2020.11.046
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: While psychotic remission in schizophrenia (SZ) has been defined by consensus and associated with a rank of clinical predictive factors, there is a lack of data of factors associated with functional remission. Objectives: To identify clinical and biological factors associated with impaired functional remission in a non selected chronic stabilized SZ outpatients. Methods: This study was a cross-sectional study carried out on all admitted SZ stabilized outpatients in an academic daily care psychiatric hospital. Functional remission was defined by a global assessment of functioning score >61. Psychotic remission was defined according to international criteria. Depression was assessed with the Calgary Depression Rating scale for Schizophrenia. Sociodemographic variables, tobacco status, clozapine treatment and obesity were reported. Chronic peripheral inflammation was defined by a highly sensitive C reactive protein serum level >3 mg/L and metabolic syndrome according to international recommendations. Results: 273 patients were included, among them 51 (18.7%) were classified in the functional remission group. In the multivariate analysis, higher rate of functional remission was associated with psychotic remission (adjusted Odd ratio = 18.2, p <0.001), lower depressive symptoms (aOR=0.8, p = 0.018) and lower peripheral inflammation (aOR=0.4, p = 0.046). No association of functional remission with age, gender, illness duration, second generation antipsychotics, clozapine treatment, tobacco smoking, obesity or metabolic syndrome has been found. Conclusion: Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in SZ independently of psychotic remission. Future intervention studies should determine if improving depressive symptoms and chronic peripheral inflammation may improve SZ patients reaching functional remission.
引用
收藏
页码:267 / 271
页数:5
相关论文
共 37 条
[1]   RELIABILITY AND VALIDITY OF A DEPRESSION RATING-SCALE FOR SCHIZOPHRENICS [J].
ADDINGTON, D ;
ADDINGTON, J ;
MATICKATYNDALE, E ;
JOYCE, J .
SCHIZOPHRENIA RESEARCH, 1992, 6 (03) :201-208
[2]   ASSESSING DEPRESSION IN SCHIZOPHRENIA - THE CALGARY DEPRESSION SCALE [J].
ADDINGTON, D ;
ADDINGTON, J ;
MATICKATYNDALE, E .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 :39-44
[3]   Remission in Schizophrenia: Critical and Systematic Review [J].
AlAqeel, Bandar ;
Margolese, Howard C. .
HARVARD REVIEW OF PSYCHIATRY, 2012, 20 (06) :281-297
[4]   Remission in schizophrenia: Proposed criteria and rationale for consensus [J].
Andreasen, NC ;
Carpenter, WT ;
Kane, JM ;
Lasser, RA ;
Marder, SR ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (03) :441-449
[5]   Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort [J].
Andrianarisoa, M. ;
Boyer, L. ;
Godin, O. ;
Brunel, L. ;
Bulzacka, E. ;
Aouizerate, B. ;
Berna, F. ;
Capdevielle, D. ;
Dorey, J. M. ;
Dubertret, C. ;
Dubreucq, J. ;
Faget, C. ;
Gabayet, F. ;
Llorca, P. M. ;
Mallet, J. ;
Misdrahi, D. ;
Rey, R. ;
Richieri, R. ;
Passerieux, C. ;
Schandrin, A. ;
Tronche, A. M. ;
Urbach, M. ;
Vidailhet, P. ;
Schurhoff, F. ;
Fond, G. ;
Andrianarisoa, M. ;
Aouizerate, B. ;
Berna, F. ;
Blanc, O. ;
Brunel, L. ;
Bulzacka, E. ;
Capdevielle, D. ;
Chereau-Boudet, I. ;
Chesnoy-Servanin, G. ;
Danion, J. M. ;
D'Amato, T. ;
Deloge, A. ;
Delorme, C. ;
Denizot, H. ;
Dorey, J. M. ;
Dubertret, C. ;
Dubreucq, J. ;
Faget, C. ;
Fluttaz, C. ;
Fond, G. ;
Fonteneau, S. ;
Gabayet, F. ;
Giraud-Baro, E. ;
Hardy-Bayle, M. C. ;
Lacelle, D. .
SCHIZOPHRENIA RESEARCH, 2017, 185 :173-181
[6]   Adjusting for multiple testing - when and how? [J].
Bender, R ;
Lange, S .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (04) :343-349
[7]   Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset [J].
Bulzacka, Ewa ;
Boyer, Laurent ;
Schurhoff, Franck ;
Godin, Ophelia ;
Berna, Fabrice ;
Brunel, Lore ;
Andrianarisoa, Meja ;
Aouizerate, Bruno ;
Capdevielle, Delphine ;
Chereau-Boudet, Isabelle ;
Chesnoy-Servanin, Gabrielle ;
Danion, Jean-Marie ;
Dubertret, Caroline ;
Dubreucq, Julien ;
Faget, Catherine ;
Gabayet, Franck ;
Le Gloahec, Tifenn ;
Llorca, Pierre-Michel ;
Mallet, Jasmina ;
Misdrahi, David ;
Rey, Romain ;
Richieri, Raphaelle ;
Passerieux, Christine ;
Roux, Paul ;
Yazbek, Hanan ;
Leboyer, Marion ;
Fond, Guillaume .
SCHIZOPHRENIA BULLETIN, 2016, 42 (05) :1290-1302
[8]   Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials [J].
Cho, Myeongju ;
Lee, Tae Young ;
Kwak, Yoo Bin ;
Yoon, Youngwoo Brian ;
Kim, Minah ;
Kwon, Jun Soo .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 (08) :742-759
[9]   Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis [J].
Dazzan, Paola ;
Lappin, Julia M. ;
Heslin, Margaret ;
Donoghue, Kim ;
Lomas, Ben ;
Reininghaus, Uli ;
Onyejiaka, Adanna ;
Croudace, Tim ;
Jones, Peter B. ;
Murray, Robin M. ;
Fearon, Paul ;
Doody, Gillian A. ;
Morgan, Craig .
PSYCHOLOGICAL MEDICINE, 2020, 50 (09) :1452-1462
[10]   Towards an improved access to psychiatric rehabilitation: availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort [J].
Dubreucq, Julien ;
Ycart, B. ;
Gabayet, F. ;
Perier, C. C. ;
Hamon, A. ;
Llorca, P. M. ;
Boyer, L. ;
Godin, O. ;
Bulzacka, E. ;
Andrianarisoa, M. ;
Aouizerate, B. ;
Berna, F. ;
Brunel, L. ;
Capdevielle, D. ;
Chereau, I ;
D'Amato, T. ;
Dubertret, C. ;
Faget, C. ;
Mallet, J. ;
Misdrahi, D. ;
Passerieux, C. ;
Rey, R. ;
Richieri, R. ;
Schandrin, A. ;
Schurhoff, F. ;
Urbach, M. ;
Vidailhet, P. ;
Giraud-Baro, E. ;
Fond, G. ;
Andrianarisoa, M. ;
Aouizerate, B. ;
Bazin, N. ;
Berna, F. ;
Blanc, O. ;
Brunel, L. ;
Bulzacka, E. ;
Capdevielle, D. ;
Chereau-Boudet, I ;
Chesnoy-Servanin, G. ;
Coulon, N. ;
Danion, J. M. ;
Deloge, A. ;
Denizot, H. ;
Dorey, J. M. ;
Dubertret, C. ;
Dubreucq, J. ;
Faget, C. ;
Fluttaz, C. ;
Fond, G. ;
Fonteneau, S. .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2019, 269 (05) :599-610